Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.33 |
| ▸ | LOX | P28300 | 1/20 | 0.32 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17451526 | 1.00 | LCK (0.52) | LCKTSHRALDH1A1TDP1MAPT | |
| SCHEMBL23389008 | 0.97 | LCK (0.54) | LCKTSHRALDH1A1TDP1MAPT | |
| SCHEMBL3456784 | 0.90 | TSHR (0.52) | LCKTSHRALDH1A1TDP1MAPT | |
| SCHEMBL714027 | 0.88 | LCK (0.65) | LCKTSHRALDH1A1TDP1LOX | |
| SCHEMBL15591979 | 0.88 | LCK (0.65) | LCKTSHRALDH1A1TDP1LOX | |
| SCHEMBL714217 | 0.88 | LCK (0.65) | LCKTSHRALDH1A1TDP1LOX | |
| SCHEMBL15591987 | 0.88 | LCK (0.65) | LCKTSHRALDH1A1TDP1LOX | |
| SCHEMBL15591981 | 0.88 | LCK (0.65) | LCKTSHRALDH1A1TDP1LOX | |
| SCHEMBL17038665 | 0.88 | LCK (0.65) | LCKTSHRALDH1A1TDP1LOX | |
| SCHEMBL8439311 | 0.88 | LCK (0.72) | LCKTSHRALDH1A1TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333375-A1 | CYANOCARBON COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12215070-B2 | Cyanocarbon compositions | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-02-04 | — | — | US | disclosed |
| EP-4061795-A1 | COMPOSITIONS COMPRISING TRISCYANOHEXANE | Ascend Performance Materials Operations LLC (US) | 2022-09-28 | — | — | EP | disclosed |
| CN-114555554-A | Composition comprising hexanetricarbonitrile | 奥升德功能材料运营有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20210155579-A1 | CYANOCARBON COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-27 | — | — | US | disclosed |
| WO-2021102286-A1 | COMPOSITIONS COMPRISING TRISCYANOHEXANE | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-27 | — | — | WO | disclosed |
| EP-0807120-B1 | RUTHENIUM HYDROGENATION CATALYSTS | DU PONT (US) | 2000-04-26 | — | — | EP | disclosed |
| EP-0807098-B1 | IMPROVED PROCESS FOR REDUCTIVE HYDROLYSIS OF NITRILES | DU PONT (US) | 1998-09-09 | — | — | EP | disclosed |
| US-5741955-A | TRANSITION METAL COMPLEX CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-04-21 | — | — | US | disclosed |
| EP-0807098-A1 | IMPROVED PROCESS FOR REDUCTIVE HYDROLYSIS OF NITRILES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-19 | — | — | EP | disclosed |
| EP-0807120-A1 | RUTHENIUM HYDROGENATION CATALYSTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-19 | — | — | EP | disclosed |
| US-5689003-A | CATALYTIC HYDROGENATION OF NITRILES TO FORM AMINES WITH COMPLEXES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| US-5554778-A | IMINATION, REDUCTIVE HYDROLYSIS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-09-10 | — | — | US | disclosed |
| WO-1996023803-A1 | RUTHENIUM HYDROGENATION CATALYSTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-08-08 | — | — | WO | disclosed |
| WO-1996023753-A1 | IMPROVED PROCESS FOR REDUCTIVE HYDROLYSIS OF NITRILES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215070-B2 | Cyanocarbon compositions | CYCS, CBR3, PCCA | LCK 1949/4885TSHR 4133/4885ALDH1A1 3668/4885 |
| US-20250333375-A1 | CYANOCARBON COMPOSITIONS | CYCS, CBR3, PCCA | LCK 1949/4885TSHR 4133/4885ALDH1A1 3668/4885 |
| US-20210155579-A1 | CYANOCARBON COMPOSITIONS | CYCS, CBR3, PCCA | LCK 1949/4885TSHR 4133/4885ALDH1A1 3668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.